Regional Monitoring EECA
by ECUO PLWH
Regional Monitoring EECA
Showing 1-32 of 32 items.
| # | Country | Source of financing | Manufacturer | Tradename | INN | Form | Price per unit ($) | Units in purchase | Units in package | Price per package ($) | Packages in purchase | Price per purchase ($) | Distributor | Year | Purchase date | Delivery date | Registered | In the list of main (vital) medications | WHO prequalification |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Republic of Moldova | Global Fund | Hetero labs Ltd. | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 0.565 | 5040 | 30 | 16.95 | 168 | 2847.6 | 2015 | Not specified | Yes | Not specified | ||||
| 2 | Republic of Tajikistan | Global Fund | Aurobindo Pharma Ltd. | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 0.4667 | 90000 | 30 | 14 | 3000 | 42000 | UNDP/UNICEF | 2016 | Not specified | Not specified | Not specified | |||
| 3 | Republic of Armenia | Global Fund | MYLAN LABORATORIES LTD | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 0.4333 | 1590 | 30 | 13 | 53 | 689 | VPP, through Partnership for Supply Chain Management (PFSCM) | 2015 | 2015-03-11 | 2015-10-14 | Not specified | Not specified | Not specified | |
| 4 | Georgia | Global Fund | MYLAN LABORATORIES LTD | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 0.4163 | 26370 | 30 | 12.49 | 879 | 10978.71 | partnership for supply. chain management (PFSCM) | 2016 | Yes | Yes | Not specified | |||
| 5 | Ukraine | Global Fund | GlaxoSmithKline | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 1.02 | 30 | 30 | 30.6 | 1 | 30.6 | 2015 | Not specified | Not specified | Not specified | ||||
| 6 | Kyrgyz Republic | Global Fund | Aurobindo Pharma Ltd. | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 0.5167 | - | 30 | 15.5 | - | - | UNDP/UNICEF | 2015 | 2014-12-31 | 2015-12-30 | Not specified | Not specified | Not specified | |
| 7 | Republic of Moldova | Global Fund | MYLAN LABORATORIES LTD | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 0.565 | 10110 | 30 | 16.95 | 337 | 5712.15 | IDA Foundation | 2016 | Not specified | Not specified | Not specified | |||
| 8 | Republic of Moldova | Global Fund | Hetero labs Ltd. | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 0.565 | 5070 | 30 | 16.95 | 169 | 2864.55 | IDA Foundation | 2015 | Not specified | Yes | Not specified | |||
| 9 | Republic of Armenia | Global Fund | MYLAN LABORATORIES LTD | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 0.4163 | 8220 | 30 | 12.49 | 274 | 3422.26 | partnership for supply. chain management (PFSCM) | 2016 | No | Yes | Not specified | |||
| 10 | Georgia | Global Fund | GlaxoSmithKline | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 1.9667 | 49440 | 30 | 59 | 1648 | 97232 | partnership for supply. chain management (PFSCM) | 2016 | Yes | Yes | Not specified | |||
| 11 | Republic of Tajikistan | Global Fund | ViiV Healthcare | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 0.5167 | 30 | 30 | 15.5 | 1 | 15.5 | 2015 | Not specified | Not specified | Not specified | ||||
| 12 | Ukraine | Global Fund | GlaxoSmithKline | Kivexa | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 0.969 | 629100 | 30 | 29.07 | 20970 | 609597.88 | 2016 | Yes | Yes | Not specified | |||
| 13 | Republic of Latvia | Government | ViiV Healthcare | Kivexa | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 11.619 | 30 | 30 | 348.57 | 1 | 348.57 | 2015 | Not specified | Not specified | Not specified | |||
| 14 | Russian Federation | Government | ViiV Healthcare | Kivexa | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 1.8 | 36000 | 30 | 54 | 1200 | 64800 | 2016 | Yes | Yes | Not specified | |||
| 15 | Republic of Poland | Government | ViiV Healthcare | Kivexa | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 14.1667 | 195000 | 30 | 425 | 6500 | 2762500 | 2015 | Not specified | Not specified | Not specified | |||
| 16 | Republic of Poland | Government | Sandoz | Abacavir + Lamivudine Sandoz | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 8.3753 | 51000 | 30 | 251.26 | 1700 | 427142 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Not specified | ||
| 17 | Republic of Lithuania | Government | Viiv Healthcare UK Limited | Kivexa | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 11.1373 | 30 | 30 | 334.12 | 1 | 334.12 | Viiv Healthcare UK Limited | 2015 | Not specified | Yes | Not specified | ||
| 18 | Republic of Poland | Government | GlaxoSmithKline | Kivexa | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 12.882 | 3000 | 30 | 386.46 | 100 | 38646 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 19 | Russian Federation | Government | ViiV Healthcare | Kivexa | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 4.002 | 4361970 | 30 | 120.06 | 145399 | 17456604 | 2015 | Not specified | Not specified | Not specified | |||
| 20 | Republic of Kazakhstan | Government | Aurobindo Pharma Ltd. | Abacavir+Lamivudim | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 0.06 | 30 | 30 | 1.8 | 1 | 1.8 | 2016 | Yes | Not specified | Yes | |||
| 21 | Ukraine | Government | GlaxoSmithKline | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 0.9797 | 171930 | 30 | 29.39 | 5731 | 168434.09 | 2015 | Not specified | Not specified | Not specified | ||||
| 22 | Ukraine | Government | Aurobindo Pharma Ltd. | Abacavir+Lamivudim | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 0.4043 | 171930 | 30 | 12.13 | 5731 | 69517.03 | 2016 | Yes | Yes | Yes | |||
| 23 | Republic of Poland | Government | Viiv Healthcare UK Limited | Kivexa | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 14.1667 | 18000 | 30 | 425 | 600 | 255000 | 2015 | Not specified | Not specified | Not specified | |||
| 24 | Republic of Latvia | Government | Viiv Healthcare UK Limited | Kivexa | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 13.188 | 197760 | 30 | 395.64 | 6592 | 2608059 | National Health Service (NHC) | 2016 | Not specified | Not specified | Not specified | ||
| 25 | Republic of Poland | Government | ViiV Healthcare | Kivexa | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 14.1667 | 66000 | 30 | 425 | 2200 | 935000 | 2015 | Not specified | Not specified | Not specified | |||
| 26 | Republic of Poland | Government | GlaxoSmithKline | Kivexa | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 12.882 | 138000 | 30 | 386.46 | 4600 | 1777716 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Not specified | ||
| 27 | Republic of Kazakhstan | Government | ViiV Healthcare | Kivexa | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 0.3777 | 3047400 | 30 | 11.33 | 101580 | 1150901.38 | 2015 | Not specified | Not specified | Not specified | |||
| 28 | Republiс of Azerbaijan | Government | ViiV Healthcare | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 1.7167 | 21960 | 30 | 51.5 | 732 | 37698 | 2015 | Yes | Yes | Not specified | ||||
| 29 | Republic of Moldova | Government | Viiv Healthcare UK Limited | Ziagen | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 5.8167 | 24870 | 30 | 174.5 | 829 | 144660.5 | Dita Estfarm SRL | Not specified | Not specified | Not specified | |||
| 30 | Republic of Lithuania | Insurance Fund | Viiv Healthcare UK Limited | Kivexa | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 7.5193 | 30 | 30 | 225.58 | 1 | 225.58 | 2016 | Yes | Yes | Not specified | |||
| 31 | Republic of Lithuania | Insurance Fund | Teva BV | Kivexa | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 7.5747 | 30 | 30 | 227.24 | 1 | 227.24 | 2016 | Yes | Yes | Yes | |||
| 32 | Ukraine | PEPFAR | MYLAN LABORATORIES LTD | Abacavir (ABC) | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 0.3733 | 966480 | 30 | 11.2 | 32216 | 360819.19 | 2016 | Yes | Not specified | Not specified |